Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma

被引：0

作者：

Takeshi Terashima ^{[1
]}

Kouki Nio ^{[1
]}

Naohiko Koshikawa ^{[2
]}

Makoto Ueno ^{[3
]}

Tadashi Toyama ^{[4
]}

Masaki Miyazawa ^{[1
]}

Tomoyuki Hayashi ^{[1
]}

Akihiro Seki ^{[1
]}

Hidetoshi Nakagawa ^{[1
]}

Noriho Iida ^{[1
]}

Shinya Yamada ^{[1
]}

Hajime Takatori ^{[1
]}

Tetsuro Shimakami ^{[1
]}

Toru Yoshimura ^{[5
]}

Eisaku Yoshida ^{[5
]}

Masatoshi Nakagawa ^{[2
]}

Motoharu Seiki ^{[5
]}

Taro Yamashita ^{[6
]}

机构：

[1] Kanazawa University Hospital,Department of Gastroenterology

[2] Tokyo Institute of Technology,School of Life Science and Technology

[3] Kanagawa Cancer Center,Department of Gastroenterology

[4] Kanazawa University Hospital,Department of Nephrology

[5] Abbott Japan LLC,Research and Development

[6] Kanazawa University,Faculty of Medicine, Institute of Medical, Pharmaceutical & Health Science

来源：

BJC Reports | / 3卷 / 1期

关键词：

D O I：

10.1038/s44276-024-00116-z

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
Chung, Kwang Hyun
Lee, Jong-Chan
Lee, Jongchan
Cho, In-Kuk
Kim, Jaihwan
Jang, Woncheol
Yoo, Byong Chul
Hwang, Jin-Hyeok
PANCREATOLOGY, 2020, 20 (07) : 1465 - 1471
[2] MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma
Chen, Da-Wei
Fan, Yao-Fu
Li, Jiang
Jiang, Xiao-Xiao
TUMOR BIOLOGY, 2013, 34 (03) : 1553 - 1557
[3] GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
Yang, Sen
Zhang, Yalu
Hua, Yuze
Cui, Ming
Wang, Mengyi
Gao, Junyi
Liu, Qiaofei
Liao, Quan
FRONTIERS IN ONCOLOGY, 2022, 12
[4] Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma
Wang, Weibin
Reiser-Erkan, Carolin
Michalski, Christoph W.
Raggi, Matthias C.
Quan, Liao
Yupei, Zhao
Friess, Helmut
Erkan, Mert
Kleeff, Joerg
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (03) : 422 - 428
[5] Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma
Fan, Jie
Yang, Michelle X.
Ouyang, Qi
Fu, Deliang
Xu, Zude
Liu, Xiuping
Mino-Kenudson, Mari
Geng, Jiang
Tang, Feng
HUMAN PATHOLOGY, 2016, 55 : 151 - 158
[6] The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Erkan, Mert
Michalski, Christoph W.
Rieder, Simon
Reiser-Erkan, Carolin
Abiatari, Ivane
Kolb, Armin
Giese, Nathalia A.
Esposito, Irene
Friess, Helmut
Kleeff, Joerg
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (10) : 1155 - 1161
[7] IKAROS: a potential prognostic marker in pancreatic ductal adenocarcinoma
Cruz Ramos, M.
Rodriguez-Remirez, M.
Minguez, P.
Cebrian, A.
del Puerto-Nevado, L.
Celdran, A.
Garcia-Foncillas Lopez, J.
ANNALS OF ONCOLOGY, 2016, 27 : 12 - 13
[8] Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Lee, Sang Hoon
Jo, Jung Hyun
Kim, Yeong Jin
Lee, Hee Seung
Chung, Moon Jae
Park, Jeong Youp
Bang, Seungmin
Park, Seung Woo
Song, Si Young
PANCREAS, 2019, 48 (05) : 662 - 669
[9] MUC13 Mucoprotein Is a Reliable Diagnostic and Prognostic Marker for Pancreatic Ductal Adenocarcinoma
Bibars, Wafi
Khan, Sheema
Jaggi, Meena
Chauhan, Subhash
Zafar, Nadeem
LABORATORY INVESTIGATION, 2017, 97 : 442A - 442A
[10] MUC13 Mucoprotein Is a Reliable Diagnostic and Prognostic Marker for Pancreatic Ductal Adenocarcinoma
Bibars, Wafi
Khan, Sheema
Jaggi, Meena
Chauhan, Subhash
Zafar, Nadeem
MODERN PATHOLOGY, 2017, 30 : 442A - 442A

← 1 2 3 4 5 →